Brand Name | COVAXIN | COVISHIELD | Sputnik V (pending emergency use authorization) |
---|
Origin | India (Bharat Biotech) | Oxford-AstraZeneca (manufactured locally by Serum Institute of India) | Russia (Gamaleya Research Institute & Crocus Medical BV) |
---|
Name | BBV152 | ChAdOx1 nCoV- 19 CoronaVirus Vaccine (Recombinant) | Gam-COVID-Vac |
---|
Age | 18 years and above | 18 years and above | 18 years and above |
---|
Number of shots | Two injections given 4 weeks apart | Two injections given 4 to 6 weeks or upto12 weeks apart | Two injections given 21 days apart |
---|
Injection site | Upper arm | Upper arm | Upper arm |
---|
Frequent Side effects | Headache, fatigue, fever, body ache, abdominal pain, nausea, vomiting, rashes | Injection site tenderness and/or pain, headache, fatigue, muscle pain, malaise, fever, chills, joint pain, nausea | Flu-like illness, injection site reactions, headache, weakness and lack of energy. |
---|
How do the vaccines work? | Inactivated coronavirus expressing the viral spike (S) protein of coronavirus | Weakened version of an adenovirus encoding a protein of coronavirus. Following administration, the coronavirus protein is expressed locally stimulating neutralizing antibody and cellular immune responses. | The two shots are two slightly different versions a cold-type virus, engineered to be harmless, as a carrier to deliver a small fragment of the spike protein of coronavirus to the body. The idea of using two different shots is to give a greater boost to the immune system |
---|
How to obtain the vaccine | Register on the Co-WIN Portal and schedule your vaccination appointment. https://www.cowin.gov.in/home; Vaccines are available from Government and Private Health Facilities as notified, known as COVID Vaccination Centres (CVCs) | Pending emergency use authorization |
---|
Reference | https://cdsco.gov.in/ https://www.bharatbiotech.com/ | https://cdsco.gov.in/ | Lancet. 2021 Feb 20;397(10275):671-681 |
---|